Generation Bio Co. (GBIO)
Total Valuation
GBIO has a market cap or net worth of $203.42 million. The enterprise value is $31.16 million.
Market Cap | 203.42M |
Enterprise Value | 31.16M |
Important Dates
The last earnings date was Wednesday, March 6, 2024, after market close.
Earnings Date | Mar 6, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
GBIO has 66.48 million shares outstanding. The number of shares has increased by 10.96% in one year.
Shares Outstanding | 66.48M |
Shares Change (YoY) | +10.96% |
Shares Change (QoQ) | +0.26% |
Owned by Insiders (%) | 14.47% |
Owned by Institutions (%) | 79.78% |
Float | 48.54M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 34.45 |
Forward PS | 43.99 |
PB Ratio | 1.00 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 5.28 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.83, with a Debt / Equity ratio of 0.48.
Current Ratio | 6.83 |
Quick Ratio | 6.87 |
Debt / Equity | 0.48 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -52.30% and return on invested capital (ROIC) is -46.03%.
Return on Equity (ROE) | -52.30% |
Return on Assets (ROA) | -31.80% |
Return on Capital (ROIC) | -46.03% |
Revenue Per Employee | $33,931 |
Profits Per Employee | -$727,655 |
Employee Count | 174 |
Asset Turnover | 0.02 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -21.07% in the last 52 weeks. The beta is 2.70, so GBIO's price volatility has been higher than the market average.
Beta (1Y) | 2.70 |
52-Week Price Change | -21.07% |
50-Day Moving Average | 2.22 |
200-Day Moving Average | 3.14 |
Relative Strength Index (RSI) | 59.98 |
Average Volume (30 Days) | 348,575 |
Short Selling Information
The latest short interest is 1.44 million, so 2.17% of the outstanding shares have been sold short.
Short Interest | 1.44M |
Short Previous Month | 1.43M |
Short % of Shares Out | 2.17% |
Short % of Float | 2.97% |
Short Ratio (days to cover) | 6.48 |
Income Statement
In the last 12 months, GBIO had revenue of $5.90 million and -$126.61 million in losses. Loss per share was -$1.96.
Revenue | 5.90M |
Gross Profit | 5.90M |
Operating Income | -138.56M |
Pretax Income | -126.61M |
Net Income | -126.61M |
EBITDA | -121.35M |
EBIT | -126.61M |
Loss Per Share | -$1.96 |
Balance Sheet
The company has $270.16 million in cash and $97.89 million in debt, giving a net cash position of $172.26 million or $2.59 per share.
Cash & Cash Equivalents | 270.16M |
Total Debt | 97.89M |
Net Cash | 172.26M |
Net Cash Per Share | $2.59 |
Equity / Book Value | 203.13M |
Book Value Per Share | 3.06 |
Working Capital | 232.70M |
Cash Flow
In the last 12 months, operating cash flow was -$52.75 million and capital expenditures -$7.40 million, giving a free cash flow of -$60.14 million.
Operating Cash Flow | -52.75M |
Capital Expenditures | -7.40M |
Free Cash Flow | -60.14M |
FCF Per Share | -$0.93 |
Margins
Gross margin is 100.00%, with operating and profit margins of -2,346.93% and -2,144.51%.
Gross Margin | 100.00% |
Operating Margin | -2,346.93% |
Pretax Margin | -2,144.51% |
Profit Margin | -2,144.51% |
EBITDA Margin | -2,055.37% |
EBIT Margin | -2,144.51% |
FCF Margin | -1,018.67% |
Dividends & Yields
GBIO does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -10.96% |
Shareholder Yield | -10.96% |
Earnings Yield | -62.24% |
FCF Yield | -29.57% |
Analyst Forecast
The average price target for GBIO is $8.00, which is 170.27% higher than the current price. The consensus rating is "Buy".
Price Target | $8.00 |
Price Target Difference | 170.27% |
Analyst Consensus | Buy |
Analyst Count | 5 |
Revenue Growth Forecast (5Y) | -24.71% |
EPS Growth Forecast (5Y) | -4.71% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
GBIO has an Altman Z-Score of -1.78 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -1.78 |
Piotroski F-Score | 1 |